A LC-FAOD Treatment from Ultragenyx and Available Resources – for US members only

Join Energy in Action host, Stephanie Tomlinson as she interviews Bridget Reineking and Sylvia Mills from Ultragenyx Pharmaceutical.

This podcast episode is intended for U.S. members of the MitoAction community. You can learn more about Dojolvi ®(triheptanoin) and find its full Prescribing Information that includes the Patient Information leaflet here.

*This podcast episode is intended for U.S. members of the MitoAction community.*

 

About the Speakers

Bridget Reineking MS, RDN, CD is the Senior Director of Global Metabolic Nutrition Programs at Ultragenyx Pharmaceutical, working within the pharmaceutical industry for almost a decade. She has two decades of experience and several publications in the area of inborn errors of metabolism, beginning her passion as a Nutrition Assistant at the Waisman Center, while attending the University of Wisconsin-Madison to receive her undergraduate degree in dietetics. Bridget went on to complete her master’s degree at Case Western Reserve University and practiced clinically at Children’s Hospital of Wisconsin-Milwaukee before joining industry.

 

 

Sylvia Mills is the Director of Patient Services, Metabolic Franchise at Ultragenyx and has over two decades of patient advocacy and pharmaceutical reimbursement experience. She has worked with diverse patient populations with rare diseases and is an expert in navigating the reimbursement process. Sylvia is committed to providing exceptional service to patients and healthcare providers by helping ensure access to treatment and lowering barriers to reimbursement.